Tesaro IPO Research Information

Tesaro IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Tesaro, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Tesaro	TSRO - NASDAQ	$12.00-$15.00	$13.50	$14.00	6.0 million	6/28/2014
Underwriter(s): Citigroup, Morgan Stanley, Leerink Swann
Co-Manager(s): BMO Capital Markets, Baird
Industry: Health Care
Filing(s): Filed 2012-03-23

Tesaro Quote & Chart - Click for current quote - TSRO

About Tesaro (adapted from Tesaro prospectus):
They are an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.

This description is adapted from Tesaro prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Tesaro "TSRO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.